English | Español
Press release submission | Feb 15, 2022

Cardiosense receives FDA Breakthrough Device designation for algorithm to identify patients at risk of decompensated heart failure

Press release submission | Feb 14, 2022

Patients benefit from new treatment for pancreatic and liver cancers, and sarcomas

Press release submission | Feb 12, 2022

Accuray TomoTherapy® Helical Radiotherapy System Helps Preserve Breast Cancer Patients' Long-term Heart and Lung Functionality

Press release submission | Feb 11, 2022

Vicore's AIR study interim analysis suggests that C21 improves lung function in IPF patients

Press release submission | Feb 11, 2022

Salience Health Implements iTether's Care Management Platform to Improve Treatment Outcomes for Depression Patients

Press release submission | Feb 10, 2022

Urology Centers of Alabama and Phosphorus Announce Partnership to Provide Holistic, Preventative Genetic Insight for Patients Through the GeneCompass™ Genetic Test

Press release submission | Feb 10, 2022

First Patients Enrolled in Prospective Randomized Multi-Center Comparative Clinical Study Evaluating Restrata® for the Treatment of Venous Leg Ulcers

Bree Gonzales | Feb 7, 2022

Mississippi pharmacist sentenced to five years for $180 million TRICARE fraud scheme

Trending
+ Pharmaceuticals
Patient Daily | Jun 30, 2025

PhRMA public affairs senior director on 340B program: 'PBMs took $140 billion in rebates and fees, driving up American medicine costs'
+ Pharmaceuticals
Patient Daily | Jun 25, 2025

Neurosurgeon at the University of California: ‘340B is being exploited for profit, not patient care’
+ Pharmaceuticals
Patient Daily | Jul 1, 2025

PhRMA chief public affairs officer on 340B drug pricing: ‘Lowering drug prices for U.S. patients starts by reining in middlemen’